PHILADELPHIA (AP) — The company that makes the opioid addiction treatment drug Suboxone has reached a $102.5 million settlement of antitrust claims with 41 states and the District of Columbia. Attorneys general sued Indivior and claimed the company schemed to keep generic competitors off the market. The deal was announced Friday. It averts a trial that was scheduled to start later this year. The settlement is distinct from other opioid-related settlements of claims that pharmaceutical companies sparked or deepened a nationwide overdose crisis. The company says settling the lawsuit allows it to focus on its mission.
BE PART OF THE CONVERSATION
KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.
Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here
If you would like to share a story idea, please submit it here.